Patient therapeutic education programs have been shown to be effective in many specialties, allowing "Improving biological and psychological parameters, allowing patients to improve their health knowledge, therapeutic adherence and sense of personal effectiveness." Several studies have shown that patient knowledge, adherence and satisfaction are better after attending a therapeutic education program.
This multidisciplinary program is presented and offered to all patients with chronic disease treated by subcutaneous biotherapy, followed by dermatologists, rheumatologists and gastroenterologists of the Lorient hospital.
The study aims to demonstrate the benefit of the Patient Therapeutic Education program at GHBS Lorient "living with a chronic inflammatory disease under biotherapy" on treatment adherence, as well as the positive impact on quality of life.
All major patients followed up on GHBS for chronic inflammatory disease treated with S/C biotherapy.
Patients not opposed to their participation in the research.
Less than 3 months between inclusion and start of Therapeutic Education Program.
Subcutaneous injection by another person.
Patients with cognitive impairment.
Persons of legal age who are the subject of a legal protection (safeguarding of justice, curatorship, guardianship), persons deprived of liberty.
Pregnant women.
All major patients followed up on GHBS for chronic inflammatory disease treated with S/C biotherapy.
Case-control
Prospective
questionnaires
Other interventionMorisky and SF12 Questionnaires delivery at inclusion, 6, 12 and 18 months
Scores of the Morisky scale
Comparison of the scores of the Morisky scale in patients with chronic inflammatory disease treated by S/C biotherapy at 18 months after inclusion versus patients who only received nurse consultation.
Scores of the Morisky scale
Comparison of scores on the Morisky scale in patients with chronic inflammatory disease treated by S/C biotherapy at 6 and 12 months after inclusion versus patients who only received nurse consultation.
SF-12 quality of life questionnaire
Comparison of the SF-12 quality of life questionnaire in patients at 6, 12 and 18 months after inclusion versus patients who only received nurse consultation.
Click on the lead sponsor to view all of their trials.
